- Home
- EW
as 07-26-2024 4:00pm EST
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
| Founded: | 1958 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 52.9B | IPO Year: | 2000 |
| Target Price: | $83.45 | AVG Volume (30 days): | 5.9M |
| Analyst Decision: | Buy | Number of Analysts: | 20 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.32 | EPS Growth: | -3.73 |
| 52 Week Low/High: | $58.93 - $96.12 | Next Earning Date: | 07-24-2024 |
| Revenue: | $6,143,400,000 | Revenue Growth: | 11.68% |
| Revenue Growth (this year): | 12.56% | Revenue Growth (next year): | 9.78% |
Stock Insider Trading Activity of Edwards Lifesciences Corporation (EW)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Jun 20 '24 | Sell | $87.47 | 5,225 | $457,012.99 | 30,561 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Jun 20 '24 | Sell | $88.11 | 400 | $35,245.00 | 35,786 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | May 21 '24 | Sell | $90.45 | 5,625 | $508,803.19 | 30,561 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Apr 30 '24 | Sell | $86.40 | 700 | $60,482.52 | 25,624 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Apr 30 '24 | Sell | $85.74 | 6,550 | $561,579.32 | 19,074 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Apr 1 '24 | Sell | $95.51 | 868 | $82,902.68 | 25,461 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Apr 1 '24 | Sell | $94.81 | 6,387 | $605,520.81 | 19,074 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Feb 29 '24 | Sell | $85.59 | 7,255 | $620,922.80 | 19,074 | SEC Form 4 |
| GALLAHUE KIERAN | EW | Director | Feb 23 '24 | Sell | $87.61 | 3,058 | $267,911.38 | 67,219 | SEC Form 4 |
| Chopra Daveen | EW | CVP, TMTT | Feb 21 '24 | Sell | $86.67 | 1,200 | $104,004.24 | 29,750 | SEC Form 4 |
| Chopra Daveen | EW | CVP, TMTT | Feb 21 '24 | Sell | $86.75 | 7,000 | $607,267.50 | 22,750 | SEC Form 4 |
| STONE HEISZ LESLIE | EW | Director | Feb 8 '24 | Sell | $86.45 | 7,056 | $609,991.20 | 26,980 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Feb 1 '24 | Sell | $78.29 | 7,255 | $567,993.95 | 19,248 | SEC Form 4 |
| Ullem Scott B. | EW | CVP, Chief Financial Officer | Dec 29 '23 | Sell | $76.55 | 14,510 | $1,110,794.19 | 19,248 | SEC Form 4 |
| Chopra Daveen | EW | CVP, TMTT | Dec 15 '23 | Sell | $78.25 | 7,000 | $547,724.10 | 23,950 | SEC Form 4 |
| Chopra Daveen | EW | CVP, TMTT | Dec 6 '23 | Sell | $70.00 | 3,500 | $245,005.60 | 23,950 | SEC Form 4 |
Latest Edwards Lifesciences Corporation News
EW Breaking Stock News: Dive into EW Ticker-Specific Updates for Smart Investing
MT Newswires
11 hours ago
Redburn Atlantic Adjusts Price Target on Edwards Lifesciences to $88 From $96
The Wall Street Journal
17 hours ago
Heard on the Street Thursday Recap: Detroit Blues
Morningstar Research
a day ago
Analyst Report: Edwards Lifesciences Corporation
The Wall Street Journal
a day ago
Heard on the Street Recap: Detroit Blues
Investopedia
a day ago
S&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key Product
Investopedia
a day ago
Edwards Lifesciences Stock Plummeted Today. Here's Why
Investor's Business Daily
a day ago
Edwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker
MT Newswires
a day ago
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Compare EW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EW Edwards Lifesciences Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.